MedPath

Comparison of Regional Anesthesia Techniques After Total Knee Arthroplasty

Not Applicable
Completed
Conditions
Postoperative Pain
Knee Arthropathy
Pain, Acute
Mobility Limitation
Interventions
Procedure: continuous anesthesia of adductor canal
Procedure: continuous anesthesia of femoral nerve
Procedure: Spinal anesthesia
Registration Number
NCT03143738
Lead Sponsor
Medical University of Lublin
Brief Summary

Comparison of continuous adductor canal block to continuous femoral nerve block in patients after total knee arthroplasty.

All patients will be anesthetized with spinal anesthesia. Continuous infusion of ropivacaine with a catheter implemented to the adductor canal or next to the femoral nerve.

The observed goals: pain intensity, the beginning and quality of rehabilitation.

Detailed Description

Written consent will be obtained a day before the surgery. Only subarachnoidally anaesthetised patients may participate in the study. Pencil-point spinal needle and bupivacaine (Marcaine Heavy Spinal 0.5 %) will be used.

Before the beginning of operation, under ultrasound control, a catheter will be implemented to one of the chosen position: the adductor canal (the middle or lower third of thigh) or near the femoral nerve (below the inguinal ligament). The local anesthetic solution of 0.2 % ropivacaine will be started with an elastomeric pump (5 mL per hour, up to 72 hours) as soon as a catheter in the right position.

The pain will be measured with VAS (visual-analogue scale) 8, 24 and 48 hours after the end of operation, and at the discharge. At the same time, i.e.: 8, 24 and 48 hours from the end of surgery, the range of flexion and extension in the operated knee will be assessed. Moreover, the possibility of patient's sitting, standing up and walking will be noted.

All parameters will be reassessed before patients' discharge from the hospital. Each patient will receive paracetamol (1.0) and metamizol (1.0) intravenously (i.v.) q6h. 5 mg of morphine may be given as required, up to 2 dosages per day as a rescue medication.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • knee arthroplasty
  • obtained consent
  • subarachnoid anaesthesia
Exclusion Criteria
  • coagulopathy
  • allergy to to local anesthetics
  • depression, antidepressant drugs treatment
  • epilepsy
  • usage of painkiller before surgery
  • addiction to alcohol or recreational drugs

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
continuous anesthesia of femoral nerveSpinal anesthesia-
continuous anesthesia of adductor canalSpinal anesthesia-
continuous anesthesia of adductor canalcontinuous anesthesia of adductor canal-
continuous anesthesia of femoral nervecontinuous anesthesia of femoral nerve-
Primary Outcome Measures
NameTimeMethod
Morphine consumption24 hours from the end of surgery

Total consumption of intravenous morphine by patients with the use of patient-controlled analgesia pump

Secondary Outcome Measures
NameTimeMethod
Knee flexion8, 24, 48 hours from the end of surgery, and at the patient discharge from the hospital (an average 4-6 days)

range of flexion in operated knee

Walking8, 24, 48 hours from the end of surgery, and at the patient discharge from the hospital (an average 4-6 days)

Possibility of walking by patients at scheduled time points

The change of acute postoperative pain8, 24, 48 hours from the end of surgery, and at the patient discharge from the hospital (an average 4-6 days)

Measured with VAS (visual-analogue scale)

Sitting8, 24, 48 hours from the end of surgery, and at the patient discharge from the hospital (an average 4-6 days)

Possibility of walking by patients at scheduled time points

Trial Locations

Locations (1)

Michał Borys

🇵🇱

Lublin, Poland

© Copyright 2025. All Rights Reserved by MedPath